Skip to content
healthcare.dev

ROFLUMILAST

NDC 43547-005, roflumilast, tablet, from Solco Healthcare US, LLC..

Product NDC
43547-005
Status
Listed
Labeler
Solco Healthcare US, LLC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208299
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43547-005 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROFLUMILAST500 ug/1

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
43547-005-034354700050330 TABLET in 1 BOTTLE (43547-005-03)
43547-005-094354700050990 TABLET in 1 BOTTLE (43547-005-09)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4251c764-7224-4f94-9de7-b6c76cb1f5cd
  • NADAC price for package 43547000503

    GET /v1/drugs/nadac/43547000503
  • NADAC price for package 43547000509

    GET /v1/drugs/nadac/43547000509

Use it

Look up 43547-005 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43547-005 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43547-005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.